Vaxcyte Inc.
PCVX | NASDAQ
$58.92
+$0.79 (+1.36%)
At close: Sep 21, 2026, 4:00 PM ET
$58.11
-$0.81 (-1.37%)
Pre-market:
Sep 22, 2026, 4:01 AM ET
Market Data
Market Cap $8.39B
Enterprise Value $7.14B
Beta 1.22
Average Volume 1.41M
Shares Outstanding (Diluted) 144.49M
Shares Change YoY 6.22%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US92243G1085
Price Performance
Price Change 1M -6.5%
Price Change 3M 13.4%
Price Change 6M 5.4%
Price Change YTD 26.8%
Price Change 1Y 76.0%
Price Change 3Y 12.3%
Price Change 5Y 128.6%
1M CAGR (ann.) -1.3%
1Y CAGR (ann.) 88.2%
5Y CAGR (ann.) 17.3%
All-Time CAGR 13.6%
Valuation
PE Ratio -7.71
Forward PE N/A
PEG Ratio 0.15
Forward PEG 0.37
PS Ratio N/A
Forward PS 97.60
PB Ratio 3.08
P/FCF Ratio -7.08
P/Adj. FCF Ratio -6.12
P/OCF Ratio -7.33
EV/Sales N/A
EV/EBIT -6.64
EV/EBITDA -6.79
EV/FCF -5.93
Earnings Yield -13.0%
FCF Yield -14.1%
Adj. FCF Yield -16.4%
Financial Health
Net Cash $1.49B
Total Debt $115.45M
Cash & Short-Term Investments $1.49B
Total Assets $3.14B
Current Ratio 5.72
Quick Ratio 5.72
Debt / Equity Ratio 0.04
Debt / EBITDA -0.11
Debt / FCF -0.10
OCF / Debt -10.06
Interest Coverage 0.00
Altman Z-Score 11.37
Piotroski F-Score 0
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -15.7%
Returns
Return on Assets -33.9%
Return on Equity -37.6%
Return on Invested Capital -40.5%
Return on Capital Employed -40.6%
Return on Tangible Assets -33.9%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -27.8%
EPS CAGR 5Y -24.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y -39.6%
FCF CAGR 5Y -44.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y 38.4%
Revenue Growth Next 3Y N/A
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$2.12
EPS Growth Est (next Q) 35.8%
Revenue Est (next Q) $12.5M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $105.57
Price Target Upside 79.2%
Cash Flow
Operating Cash Flow $-1.16B
Free Cash Flow $-1.2B
Adj. Free Cash Flow $-1.39B
FCF Per Share -$8.32
OCF Per Share -$8.04
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-865K
Operating Income $-1.17B
EBITDA $-1.05B
Net Income $-1.06B
EPS (Diluted) -$7.64
Revenue / Employee N/A
Profit / Employee $-2.1M
Employees 507
Add to Watchlist
Select watchlists to add or remove PCVX